Kyle Malady Dexcom Inc (DXCM) insider trading activity

DXCM Quotes by TradingView

Kyle Malady is Director of DEXCOM INC. Currently has a direct ownership of 18,142 shares of DXCM, which is worth approximately $1.44 Million. The most recent transaction as insider was on May 22, 2024, when has been sold 2,613 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.1K
0% 3M change
16.83% 12M change
Total Value Held $1.44 Million

Kyle Malady Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2024
BUY
Grant, award, or other acquisition
-
2,613 Added 12.59%
18,142 Common Stock
May 18 2023
BUY
Grant, award, or other acquisition
-
2,885 Added 15.67%
15,529 Common Stock
May 20 2022
BUY
Grant, award, or other acquisition
-
979 Added 23.65%
3,161 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
910 Added 29.43%
2,182 Common Stock
Oct 11 2020
BUY
Grant, award, or other acquisition
-
1,272 Added 50.0%
1,272 Common Stock

Also insider at

VZ
VERIZON COMMUNICATIONS INC Communication Services
EVP and Group CEO-VZ Business
KM

Kyle Malady

Director
New York, NY

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DXCM